2024-04-012025-03-312025-03-31false06349731YOR LOCAL MEDICAL COMMITTEE LIMITED2025-12-1782110falseiso4217:GBPxbrli:pure063497312024-03-31063497312025-03-31063497312024-04-012025-03-31063497312023-03-31063497312024-03-31063497312023-04-012024-03-3106349731bus:SmallEntities2024-04-012025-03-3106349731bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3106349731bus:FullAccounts2024-04-012025-03-3106349731bus:CompanyLimitedByGuarantee2024-04-012025-03-3106349731core:WithinOneYear2025-03-3106349731core:AfterOneYear2025-03-3106349731core:WithinOneYear2024-03-3106349731core:AfterOneYear2024-03-3106349731core:ShareCapital2025-03-3106349731core:SharePremium2025-03-3106349731core:RevaluationReserve2025-03-3106349731core:OtherReservesSubtotal2025-03-3106349731core:RetainedEarningsAccumulatedLosses2025-03-3106349731core:ShareCapital2024-03-3106349731core:SharePremium2024-03-3106349731core:RevaluationReserve2024-03-3106349731core:OtherReservesSubtotal2024-03-3106349731core:RetainedEarningsAccumulatedLosses2024-03-3106349731core:LandBuildings2025-03-3106349731core:PlantMachinery2025-03-3106349731core:Vehicles2025-03-3106349731core:FurnitureFittings2025-03-3106349731core:OfficeEquipment2025-03-3106349731core:NetGoodwill2025-03-3106349731core:IntangibleAssetsOtherThanGoodwill2025-03-3106349731core:ListedExchangeTraded2025-03-3106349731core:UnlistedNon-exchangeTraded2025-03-3106349731core:LandBuildings2024-03-3106349731core:PlantMachinery2024-03-3106349731core:Vehicles2024-03-3106349731core:FurnitureFittings2024-03-3106349731core:OfficeEquipment2024-03-3106349731core:NetGoodwill2024-03-3106349731core:IntangibleAssetsOtherThanGoodwill2024-03-3106349731core:ListedExchangeTraded2024-03-3106349731core:UnlistedNon-exchangeTraded2024-03-3106349731core:LandBuildings2024-04-012025-03-3106349731core:PlantMachinery2024-04-012025-03-3106349731core:Vehicles2024-04-012025-03-3106349731core:FurnitureFittings2024-04-012025-03-3106349731core:OfficeEquipment2024-04-012025-03-3106349731core:NetGoodwill2024-04-012025-03-3106349731core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3106349731core:ListedExchangeTraded2024-04-012025-03-3106349731core:UnlistedNon-exchangeTraded2024-04-012025-03-3106349731core:MoreThanFiveYears2024-04-012025-03-3106349731core:Non-currentFinancialInstruments2025-03-3106349731core:Non-currentFinancialInstruments2024-03-3106349731dpl:CostSales2024-04-012025-03-3106349731dpl:DistributionCosts2024-04-012025-03-3106349731core:LandBuildings2024-04-012025-03-3106349731core:PlantMachinery2024-04-012025-03-3106349731core:Vehicles2024-04-012025-03-3106349731core:FurnitureFittings2024-04-012025-03-3106349731core:OfficeEquipment2024-04-012025-03-3106349731dpl:AdministrativeExpenses2024-04-012025-03-3106349731core:NetGoodwill2024-04-012025-03-3106349731core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3106349731dpl:GroupUndertakings2024-04-012025-03-3106349731dpl:ParticipatingInterests2024-04-012025-03-3106349731dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3106349731core:ListedExchangeTraded2024-04-012025-03-3106349731dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3106349731core:UnlistedNon-exchangeTraded2024-04-012025-03-3106349731dpl:CostSales2023-04-012024-03-3106349731dpl:DistributionCosts2023-04-012024-03-3106349731core:LandBuildings2023-04-012024-03-3106349731core:PlantMachinery2023-04-012024-03-3106349731core:Vehicles2023-04-012024-03-3106349731core:FurnitureFittings2023-04-012024-03-3106349731core:OfficeEquipment2023-04-012024-03-3106349731dpl:AdministrativeExpenses2023-04-012024-03-3106349731core:NetGoodwill2023-04-012024-03-3106349731core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3106349731dpl:GroupUndertakings2023-04-012024-03-3106349731dpl:ParticipatingInterests2023-04-012024-03-3106349731dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3106349731core:ListedExchangeTraded2023-04-012024-03-3106349731dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3106349731core:UnlistedNon-exchangeTraded2023-04-012024-03-3106349731core:NetGoodwill2025-03-3106349731core:IntangibleAssetsOtherThanGoodwill2025-03-3106349731core:LandBuildings2025-03-3106349731core:PlantMachinery2025-03-3106349731core:Vehicles2025-03-3106349731core:FurnitureFittings2025-03-3106349731core:OfficeEquipment2025-03-3106349731core:AfterOneYear2025-03-3106349731core:WithinOneYear2025-03-3106349731core:ListedExchangeTraded2025-03-3106349731core:UnlistedNon-exchangeTraded2025-03-3106349731core:ShareCapital2025-03-3106349731core:SharePremium2025-03-3106349731core:RevaluationReserve2025-03-3106349731core:OtherReservesSubtotal2025-03-3106349731core:RetainedEarningsAccumulatedLosses2025-03-3106349731core:NetGoodwill2024-03-3106349731core:IntangibleAssetsOtherThanGoodwill2024-03-3106349731core:LandBuildings2024-03-3106349731core:PlantMachinery2024-03-3106349731core:Vehicles2024-03-3106349731core:FurnitureFittings2024-03-3106349731core:OfficeEquipment2024-03-3106349731core:AfterOneYear2024-03-3106349731core:WithinOneYear2024-03-3106349731core:ListedExchangeTraded2024-03-3106349731core:UnlistedNon-exchangeTraded2024-03-3106349731core:ShareCapital2024-03-3106349731core:SharePremium2024-03-3106349731core:RevaluationReserve2024-03-3106349731core:OtherReservesSubtotal2024-03-3106349731core:RetainedEarningsAccumulatedLosses2024-03-3106349731core:NetGoodwill2023-03-3106349731core:IntangibleAssetsOtherThanGoodwill2023-03-3106349731core:LandBuildings2023-03-3106349731core:PlantMachinery2023-03-3106349731core:Vehicles2023-03-3106349731core:FurnitureFittings2023-03-3106349731core:OfficeEquipment2023-03-3106349731core:AfterOneYear2023-03-3106349731core:WithinOneYear2023-03-3106349731core:ListedExchangeTraded2023-03-3106349731core:UnlistedNon-exchangeTraded2023-03-3106349731core:ShareCapital2023-03-3106349731core:SharePremium2023-03-3106349731core:RevaluationReserve2023-03-3106349731core:OtherReservesSubtotal2023-03-3106349731core:RetainedEarningsAccumulatedLosses2023-03-3106349731core:AfterOneYear2024-04-012025-03-3106349731core:WithinOneYear2024-04-012025-03-3106349731core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3106349731core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3106349731core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3106349731core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3106349731core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3106349731core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3106349731core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3106349731core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3106349731core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3106349731core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3106349731core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3106349731core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3106349731core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3106349731core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3106349731core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3106349731core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3106349731core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3106349731core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3106349731core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3106349731core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3106349731core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3106349731core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3106349731core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3106349731core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3106349731core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3106349731core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3106349731core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3106349731bus:Director12024-04-012025-03-3106349731bus:Director22024-04-012025-03-3106349731bus:Director32024-04-012025-03-3106349731bus:Director42024-04-012025-03-3106349731bus:Director52024-04-012025-03-3106349731core:FurnitureFittingsToolsEquipment2024-03-3106349731core:FurnitureFittingsToolsEquipment2024-04-012025-03-3106349731core:FurnitureFittingsToolsEquipment2025-03-31

YOR LOCAL MEDICAL COMMITTEE LIMITED

Registered Number
06349731
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

YOR LOCAL MEDICAL COMMITTEE LIMITED
Company Information
for the year from 1 April 2024 to 31 March 2025

Directors

HANN, Danielle Claire, Dr
MCGREGOR, Brian, Dr
MORIARTY, Andrew Stephen, Dr
PATTERSON, Stephen, Dr
TYRER, Sally, Dr

Registered Address

First Floor 87-89 Leeds Road
Harrogate
North Yorkshire
HG2 8BE

Registered Number

06349731 (England and Wales)
YOR LOCAL MEDICAL COMMITTEE LIMITED
Statement of Financial Position
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Intangible assets347,417-
Tangible assets529,07316,048
76,49016,048
Current assets
Debtors6236,787207,058
Cash at bank and on hand1,298,886169,196
1,535,673376,254
Creditors amounts falling due within one year7(417,171)(392,302)
Net current assets (liabilities)1,118,502(16,048)
Total assets less current liabilities1,194,992-
Net assets1,194,992-
Capital and reserves
Profit and loss account1,194,992-
Reserves1,194,992-
The financial statements were approved and authorised for issue by the Board of Directors on 17 December 2025, and are signed on its behalf by:
MCGREGOR, Brian, Dr
Director
Registered Company No. 06349731
YOR LOCAL MEDICAL COMMITTEE LIMITED
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by guarantee and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Basis of preparation
The financial statements have been prepared under the historical cost convention on a going concern basis unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the rendering of services. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Defined contribution pension plan
The company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the company pays fixed contributions into a separate entity. Once the contributions have been paid the company has no further obligation. Contributions to defined contribution plans are expensed in the period to which they relate. Amounts not paid are shown in other creditors in the Statement of Financial Position. The assets of the plan are held separately from the company in independently administered funds.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Intangible assets
Intangible assets are stated at cost less accumulated amortisation and accumulated impairment losses. The assets are reviewed for impairment if the above factors indicate that the carrying amount may be impaired. Amortisation is included in 'administrative expenses' in the profit and loss account.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. The assets residual values, useful lives and depreciation methods are reviewed and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date. Gains and losses on disposal are determined by comparing the proceeds with the carrying amount and are recognised in the Income Statement. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)Straight line (years)
Land and buildings-10
Fixtures and fittings25-
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
2.Average number of employees

20252024
Average number of employees during the year1311
3.Intangible assets

Other

Total

££
Cost or valuation
Additions53,55353,553
At 31 March 2553,55353,553
Amortisation and impairment
Charge for year6,1366,136
At 31 March 256,1366,136
Net book value
At 31 March 2547,41747,417
At 31 March 24--
4.Useful life of intangible assets
Intangible assets are not permitted to have an indefinite life and must be amortised over their estimated useful life. The estimated useful life of the website has been set at 4 years and the asset will be amortised on a straight line basis over that period.
5.Tangible fixed assets

Land & buildings

Fixtures & fittings

Total

£££
Cost or valuation
At 01 April 24-76,77876,778
Additions14,1973,39217,589
At 31 March 2514,19780,17094,367
Depreciation and impairment
At 01 April 24-60,73060,730
Charge for year-4,5644,564
At 31 March 25-65,29465,294
Net book value
At 31 March 2514,19714,87629,073
At 31 March 24-16,04816,048
6.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables78913,351
Other debtors172,538175,924
Prepayments and accrued income63,46017,783
Total236,787207,058
7.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables58,60412,375
Taxation and social security42,898354
Other creditors304,195119,869
Accrued liabilities and deferred income11,474259,704
Total417,171392,302
8.Pension commitments
The company operates a defined contribution pension scheme for employees. The assets of the scheme are held separately from those of the company in an independently administered fund. At the balance sheet date, unpaid contributions of £6,679 (2024- £7,320) were due to the fund. They are included in other creditors.